<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib19">
 <label>19</label>
 <element-citation publication-type="journal" id="sref19">
  <person-group person-group-type="author">
   <name>
    <surname>Wedemeyer</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Yurdaydin</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hardtke</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial</article-title>
  <source>Lancet Infect Dis</source>
  <volume>19</volume>
  <issue>3</issue>
  <year>2019</year>
  <fpage>275</fpage>
  <lpage>286</lpage>
  <pub-id pub-id-type="pmid">30833068</pub-id>
 </element-citation>
</ref>
